The effect of dietary lysine on growth, carcass composition, and lipid metabolism in high-lean growth gilts fed from 72 to 136 kilograms.
One hundred fourteen high-lean growth gilts (72.5 kg BW) were used to determine the apparent digestible lysine requirement for maximum growth performance and carcass protein deposition rate from 72.5 to 136 kg BW. The experiment was a randomized complete block design with initial BW used to establish blocks. Six dietary treatments were included, ranging from .44 to .94% (.10% increments) apparent digestible lysine (.62 to 1.13% total lysine) with six replicate pens per treatment and three pigs per pen. Pig weights and feed consumption were collected weekly to determine ADG, ADFI, and gain: feed ratio (G/F). Six gilts were slaughtered at 72.5 kg BW to determine initial carcass composition. When the mean weight of pigs in a pen reached 104 or 136 kg, one pig per pen was selected (closest to 104 or 136 kg, respectively) and slaughtered for determination of carcass measurements and composition. From 72.5 to 104 kg and from 104 to 136 kg, ADG and G/F increased (linear, P < .05; quadratic, P < .10, respectively) as apparent digestible lysine increased. From 72.5 to 136 kg, G/F increased (quadratic, P < .10) as apparent digestible lysine increased. Average backfat thickness and longissimus muscle area at 104 kg were not influenced (P > .10) by apparent digestible lysine. However, average backfat thickness increased (quadratic, P < .05) with increasing digestible lysine for gilts slaughtered at 136 kg. Carcass CP accretion was not influenced (P > .10) from 72.5 to 104 kg but tended to increase (linear, P < .10) from 72.5 to 136 kg as digestible lysine increased. Plasma and longissimus muscle cholesterol concentrations were unaffected (P > .10) by increasing digestible lysine. These results suggest that high-lean growth gilts require greater dietary lysine than current NRC (1988) estimates to maximize ADG, G/F, and carcass CP accretion from 72.5 to 104 and from 104 to 136 kg.
Friesen
K G
KG
Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506-0201, USA.
Nelssen
J L
JL
Goodband
R D
RD
Tokach
M D
MD
Unruh
J A
JA
Kropf
D H
DH
Kerr
B J
BJ
D000818:Animals; D001823:Body Composition / Q000187:drug effects* / Q000502:physiology; D002784:Cholesterol / Q000097:blood; D004032:Diet / Q000592:standards / Q000662:veterinary*; D005260:Female; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis; D008239:Lysine / Q000008:administration & dosage / Q000494:pharmacology*; D008460:Meat / Q000592:standards*; D018482:Muscle, Skeletal / Q000737:chemistry / Q000378:metabolism; D011897:Random Allocation; D013552:Swine / Q000254:growth & development* / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol; D008239:Lysine